cefuroxime has been researched along with Endocarditis, Bacterial in 9 studies
Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.
Endocarditis, Bacterial: Inflammation of the ENDOCARDIUM caused by BACTERIA that entered the bloodstream. The strains of bacteria vary with predisposing factors, such as CONGENITAL HEART DEFECTS; HEART VALVE DISEASES; HEART VALVE PROSTHESIS IMPLANTATION; or intravenous drug use.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The Ministry of Health has recently alerted practitioners to the possible risk of heart valve damage following the long-term use of weight-loss drugs fenfluramine (Ponderax) and dexfenfluramine (Adifax)." | 1.30 | Prevention of infective endocarditis associated with dental treatment and other medical interventions. National Heart Foundation. ( Ellis-Pegler, RB; Hay, KD; Lang, SD; Neutze, JM; Swinburn, BA, 1999) |
| "Ceftazidime, cefuroxime and methicillin proved equally effective in the therapy of experimental Staphylococcus aureus endocarditis in rabbits with a dosing regimen of 40 mg/kg intramuscularly at 8-hourly intervals for three days." | 1.27 | Comparison of ceftazidime, cefuroxime and methicillin in the treatment of Staphylococcus aureus endocarditis in rabbits. ( Acred, P; McColm, AA; Ryan, DM, 1984) |
| " The area under the concentration/time curve for ceftazidime in vegetations over a post dosing 6 h period was approximately five times greater than that for cefuroxime and three times that for methicillin." | 1.27 | Penetration of beta-lactam antibiotics into cardiac vegetations, aorta and heart muscle in experimental Staphylococcus aureus endocarditis: comparison of ceftazidime, cefuroxime and methicillin. ( McColm, AA; Ryan, DM, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (55.56) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Petzsch, M | 1 |
| Leber, W | 1 |
| Westphal, B | 1 |
| Crusius, S | 1 |
| Reisinger, EC | 1 |
| McColm, AA | 2 |
| Ryan, DM | 2 |
| Acred, P | 1 |
| Mucklow, MG | 1 |
| Behan, WM | 1 |
| Patel, AR | 1 |
| Timmis, AD | 1 |
| Crofts, MA | 1 |
| Metcalfe, J | 1 |
| Monaghan, MJ | 1 |
| Sharp, J | 1 |
| Jackson, G | 1 |
| Bíró, L | 1 |
| Lengyel, M | 1 |
| Koltai, M | 1 |
| Hodics, T | 1 |
| Ellis-Pegler, RB | 1 |
| Hay, KD | 1 |
| Lang, SD | 1 |
| Neutze, JM | 1 |
| Swinburn, BA | 1 |
| Lawson, PA | 1 |
| Nikolaitchouk, N | 1 |
| Falsen, E | 1 |
| Westling, K | 1 |
| Collins, MD | 1 |
| Yinnon, AM | 1 |
| Klutstein, M | 1 |
| Balkin, J | 1 |
9 other studies available for cefuroxime and Endocarditis, Bacterial
| Article | Year |
|---|---|
Progressive Staphylococcus lugdunensis endocarditis despite antibiotic treatment.
Topics: Abscess; Aged; Aorta, Thoracic; Aortic Valve; Cefuroxime; Disease Progression; Dose-Response Relatio | 2004 |
Comparison of ceftazidime, cefuroxime and methicillin in the treatment of Staphylococcus aureus endocarditis in rabbits.
Topics: Animals; Ceftazidime; Cefuroxime; Cephalosporins; Endocarditis, Bacterial; Female; Methicillin; Micr | 1984 |
Cefuroxime therapy in infective endocarditis.
Topics: Cefuroxime; Cephalosporins; Endocarditis, Bacterial; Humans; Streptococcal Infections | 1980 |
Gonococcal endocarditis with penicillin-induced bone marrow hypoplasia. Role of echocardiography.
Topics: Adolescent; Agranulocytosis; Bone Marrow; Cefuroxime; Echocardiography; Endocarditis, Bacterial; Fem | 1981 |
[Successfully treated Salmonella enteritidis endocarditis].
Topics: Brain Diseases; Cefuroxime; Ciprofloxacin; Echocardiography; Endocarditis, Bacterial; Hematoma; Huma | 1995 |
Prevention of infective endocarditis associated with dental treatment and other medical interventions. National Heart Foundation.
Topics: Adult; Anti-Obesity Agents; Antibiotic Prophylaxis; Aortic Valve Insufficiency; Cefuroxime; Cephalos | 1999 |
Actinomyces funkei sp. nov., isolated from human clinical specimens.
Topics: Actinomycetales; Adult; Cefuroxime; DNA, Bacterial; DNA, Ribosomal; Drug Therapy, Combination; Endoc | 2001 |
Gonococcal endocarditis: a rare disease.
Topics: Adult; Aortic Valve; Cefuroxime; Endocarditis, Bacterial; Gonorrhea; Humans; Male; Neisseria gonorrh | 1988 |
Penetration of beta-lactam antibiotics into cardiac vegetations, aorta and heart muscle in experimental Staphylococcus aureus endocarditis: comparison of ceftazidime, cefuroxime and methicillin.
Topics: Animals; Anti-Bacterial Agents; Body Fluids; Ceftazidime; Cefuroxime; Endocarditis, Bacterial; Femal | 1985 |